Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis
Carlo Mümmler, Pontus Mertsch, Michaela Barnikel, Frank Haubner, Ulf Schönermarck, Ulrich Grabmaier, Hendrik Schulze-Koops, Jürgen Behr, Nikolaus Kneidinger, Katrin Milger
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 June 2024.
All research outputs
#23,512,560
of 26,179,045 outputs
Outputs from Journal of Asthma and Allergy
#501
of 557 outputs
Outputs of similar age
#180,701
of 225,145 outputs
Outputs of similar age from Journal of Asthma and Allergy
#2
of 3 outputs
Altmetric has tracked 26,179,045 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 557 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,145 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.
